673 related articles for article (PubMed ID: 15576204)
21. A cluster of positively charged amino acids in the alpha-chain of C4b-binding protein (C4BP) is pivotal for the regulation of the complement system and the interaction with bacteria.
Blom AM
Scand J Clin Lab Invest Suppl; 2000; 233():37-49. PubMed ID: 11317941
[TBL] [Abstract][Full Text] [Related]
22. A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP.
Johnsson E; Thern A; Dahlbäck B; Hedén LO; Wikström M; Lindahl G
J Immunol; 1996 Oct; 157(7):3021-9. PubMed ID: 8816411
[TBL] [Abstract][Full Text] [Related]
23. Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci.
Good MF; Pandey M; Batzloff MR; Tyrrell GJ
Expert Rev Vaccines; 2015; 14(11):1459-70. PubMed ID: 26485214
[TBL] [Abstract][Full Text] [Related]
24. Changing epidemiology of acute rheumatic fever in the United States.
Lee GM; Wessels MR
Clin Infect Dis; 2006 Feb; 42(4):448-50. PubMed ID: 16421786
[No Abstract] [Full Text] [Related]
25. Variation of multifunctional surface binding proteins--a virulence strategy for group A streptococci?
Boyle MD
J Theor Biol; 1995 Apr; 173(4):415-26. PubMed ID: 7783451
[TBL] [Abstract][Full Text] [Related]
26. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.
Olive C; Ho MF; Dyer J; Lincoln D; Barozzi N; Toth I; Good MF
J Infect Dis; 2006 Jun; 193(12):1666-76. PubMed ID: 16703510
[TBL] [Abstract][Full Text] [Related]
27. Group A streptococcal vaccines: facts versus fantasy.
Steer AC; Batzloff MR; Mulholland K; Carapetis JR
Curr Opin Infect Dis; 2009 Dec; 22(6):544-52. PubMed ID: 19797947
[TBL] [Abstract][Full Text] [Related]
28. Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein.
Courtney HS; Hasty DL; Dale JB
Mol Microbiol; 2006 Feb; 59(3):936-47. PubMed ID: 16420362
[TBL] [Abstract][Full Text] [Related]
29. Human IgG Increases Virulence of
Ermert D; Weckel A; Magda M; Mörgelin M; Shaughnessy J; Rice PA; Björck L; Ram S; Blom AM
J Immunol; 2018 May; 200(10):3495-3505. PubMed ID: 29626087
[No Abstract] [Full Text] [Related]
30. Molecular biology of Group A
Brahmadathan NK
Indian J Med Microbiol; 2017; 35(2):176-183. PubMed ID: 28681803
[TBL] [Abstract][Full Text] [Related]
31. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
[TBL] [Abstract][Full Text] [Related]
32. The quest for GAS vaccine.
Pandey M; Good MF
Oncotarget; 2015 Oct; 6(33):34063-4. PubMed ID: 26485764
[No Abstract] [Full Text] [Related]
33. Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes.
De Amicis KM; Freschi de Barros S; Alencar RE; Postól E; Martins Cde O; Arcuri HA; Goulart C; Kalil J; Guilherme L
Vaccine; 2014 Jul; 32(32):4104-10. PubMed ID: 23994376
[TBL] [Abstract][Full Text] [Related]
34. Membrane cofactor protein (MCP, CD46) binding to clinical isolates of Streptococcus pyogenes: binding to M type 18 strains is independent of Emm or Enn proteins.
Feito MJ; Sánchez A; Oliver MA; Pérez-Caballero D; Rodríguez de Córdoba S; Albertí S; Rojo JM
Mol Immunol; 2007 Jul; 44(14):3571-9. PubMed ID: 17467801
[TBL] [Abstract][Full Text] [Related]
35. The deficient cleavage of M protein-bound IgG by IdeS: insight into the escape of Streptococcus pyogenes from antibody-mediated immunity.
Su YF; Chuang WJ; Wang SM; Chen WY; Chiang-Ni C; Lin YS; Wu JJ; Liu CC
Mol Immunol; 2011 Oct; 49(1-2):134-42. PubMed ID: 21925735
[TBL] [Abstract][Full Text] [Related]
36. Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides.
Olive C; Hsien K; Horváth A; Clair T; Yarwood P; Toth I; Good MF
Vaccine; 2005 Mar; 23(17-18):2298-303. PubMed ID: 15755615
[TBL] [Abstract][Full Text] [Related]
37. M protein-mediated plasminogen binding is essential for the virulence of an invasive Streptococcus pyogenes isolate.
Sanderson-Smith ML; Dinkla K; Cole JN; Cork AJ; Maamary PG; McArthur JD; Chhatwal GS; Walker MJ
FASEB J; 2008 Aug; 22(8):2715-22. PubMed ID: 18467595
[TBL] [Abstract][Full Text] [Related]
38. Streptococcal M protein: structural studies of the hypervariable region, free and bound to human C4BP.
André I; Persson J; Blom AM; Nilsson H; Drakenberg T; Lindahl G; Linse S
Biochemistry; 2006 Apr; 45(14):4559-68. PubMed ID: 16584191
[TBL] [Abstract][Full Text] [Related]
39. Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection.
Hoe NP; Vuopio-Varkila J; Vaara M; Grigsby D; De Lorenzo D; Fu YX; Dou SJ; Pan X; Nakashima K; Musser JM
J Infect Dis; 2001 Feb; 183(4):633-9. PubMed ID: 11170990
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein.
Bauer MJ; Georgousakis MM; Vu T; Henningham A; Hofmann A; Rettel M; Hafner LM; Sriprakash KS; McMillan DJ
Vaccine; 2012 Mar; 30(12):2197-205. PubMed ID: 22265945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]